EZH2 and cancer: Reports indicate that targeting EZH2 can modulate the H3K27me3 level of HMGA2 to inhibit PI3K/Akt phosphorylation, thereby suppressing cancer cell proliferation and reducing the resistance of CRC to oxaliplatin.523 In addition, some histone demethylases are also implicated in the development of radiation resistance.